explore -WSS

explore

author：knowledge 2025-09-27 09:58:53 - browse：58435

Hospitals, pharmacies, and other health care providers are getting stuck in an insurance processing logjam after UnitedHealth Group disclosed a cyberattack within a recently acquired subsidiary that serves as a central hub for payments across the industry.

The cyberattack and subsequent system outage within UnitedHealth’s Change Healthcare has caught the attention of federal law enforcement agencies. The FBI, Cybersecurity and Infrastructure Security Agency, and Department of Health and Human Services will be on a call Friday afternoon with executives from UnitedHealth, the American Hospital Association, and the Health Information Sharing and Analysis Center, which is a group of hospitals, insurers, and other health care companies that share information on cyber threats, according to a hospital executive who shared the call details with STAT.

The severity of the attack started to become more apparent Thursday after UnitedHealth disclosed a “suspected nation-state” is behind the cyberattack, which began on Wednesday. UnitedHealth has “retained leading security experts, is working with law enforcement, and notified customers, clients, and certain government agencies,” the company said in its investor disclosure. The company took down its Change Healthcare payment systems, which remain out. It would not disclose any other information and directed STAT to its update page.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Hearing on Medicare drug price negotiation gets unusually heated

knowledge

WSS

EpiPen alternative approval delay highlights citizen petition issue

FDA investigates CAR

Fetal surgery at risk from Dobbs and new abortion restrictions

UnitedHealth’s Optum accused of antitrust violations in California

EpiPen alternative approval delay highlights citizen petition issue

Mayo Clinic plans $5B tech

focus

explore

leisure time

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Despite FDA concern, risk that CAR

Supreme Court strikes down use of affirmative action

As biotech industry slumps, bioscience job market is upside down

Activists slam private health insurers over coverage restrictions

It's been 20 years since Dolly the sheep. Where's my clone?

Guidelines to prevent youth baseball injuries need more muscle

30 years of 'Listening to Prozac'

Novavax promises a turnaround & Lilly roils the obesity market

Disappointing trial forces Pfizer to pivot on obesity medicine plans

focus

It's been 20 years since Dolly the sheep. Where's my clone?

As biotech industry slumps, bioscience job market is upside down

BIO selects John Crowley as new CEO

Changes to biosimilar regulatory framework must prioritize patients

Pediatric cancer treatments threatened by a new FDA policy

Second xenotransplant done with gene

Wikipedia

explore

knowledge

explore